Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.34
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 412.44M | 386.65M | 372.23M | 394.58M | 476.17M |
| Total Depreciation and Amortization | 115.45M | 112.11M | 115.34M | 115.34M | 128.01M |
| Total Amortization of Deferred Charges | 14.01M | 16.87M | 14.04M | 14.04M | 7.69M |
| Total Other Non-Cash Items | -92.89M | 91.17M | 11.65M | 88.00M | -92.36M |
| Change in Net Operating Assets | -133.54M | -310.89M | -134.41M | -134.41M | -181.49M |
| Cash from Operations | 315.48M | 295.91M | 378.85M | 477.54M | 338.01M |
| Capital Expenditure | -170.10M | -147.07M | -143.59M | -156.86M | -178.17M |
| Sale of Property, Plant, and Equipment | 1.07M | 1.03M | 337.10K | 327.70K | 1.19M |
| Cash Acquisitions | -3.20K | 312.90K | -216.20K | -216.20K | -216.20K |
| Divestitures | 1.40K | -135.20K | -- | -- | -- |
| Other Investing Activities | -541.32M | -791.77M | -744.68M | -669.28M | -534.58M |
| Cash from Investing | -710.36M | -937.63M | -888.16M | -826.02M | -711.78M |
| Total Debt Issued | 11.18B | 11.09B | 9.01B | 9.95B | 10.67B |
| Total Debt Repaid | -10.46B | -9.09B | -8.53B | -8.65B | -9.74B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -328.04M | -255.17M | -322.25M | -321.42M | -230.17M |
| Other Financing Activities | 1.04B | 153.75M | -71.51M | 5.64M | 259.81M |
| Cash from Financing | -84.48M | 41.85M | -267.26M | -138.11M | -63.57M |
| Foreign Exchange rate Adjustments | 850.70K | 1.15M | 1.52M | 991.50K | 879.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -478.51M | -598.72M | -775.05M | -485.61M | -436.45M |